Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio - PR Newswire
Source:PRNewswire
VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy…
Related Articles
Treasuries Decline on News Chinese Banks Asked to Limit US Bonds - bloomberg.com
Treasuries edged higher to open a consequential week, with traders awaiting readings on the labor …
Lawyers increasingly have to convince clients that AI chatbots give bad advice - NL Times
Dutch lawyers increasingly have to convince clients that they can’t rely on AI-generated legal …
S Korean crypto firm accidentally pays out $40bn in bitcoin - BBC
The company quickly realised its mistake and managed to recover virtually all the missing tokens …
The last line of defense against Paramount megadeal - Politico
The California attorney general is coordinating his antitrust review of the roughly $110 billion …